For people who are avoiding dbs and looking for a treatment that may provide neuroregeneration -- watch for the upcoming the CERE-120 phase II gene therapy multi-center trial coming later this fall of 2006.

They use neurturin -- a neurotrophic factor. Phase I safety trial was a success, and details will be published soon.

ceregene press releases

about phase I

pdf presentation of phase I study design


jean